SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Fox S)
 

Search: WFRF:(Fox S) > Social Sciences > Johansson Gunnar > Work productivity l...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden

Banefelt, J. (author)
Quantify Research, Sweden
Hallberg, S. (author)
Quantify Research, Sweden
Fox, K. M. (author)
Strateg Healthcare Solut LLC, MD USA
show more...
Mesterton, J. (author)
Karolinska Institutet
Paoli, C. J. (author)
Amgen Inc, CA 91320 USA
Johansson, Gunnar (author)
Uppsala universitet,Allmänmedicin och preventivmedicin,Uppsala University, Sweden
Levin, Lars-Åke (author)
Linköpings universitet,Avdelningen för hälso- och sjukvårdsanalys,Medicinska fakulteten
Sobocki, P. (author)
Karolinska Institute, Sweden; IMS Heatlh, Sweden
Gandra, S. R. (author)
Amgen Inc, CA 91320 USA
show less...
 (creator_code:org_t)
2015-11-25
2016
English.
In: European Journal of Health Economics. - : SPRINGER. - 1618-7598 .- 1618-7601. ; 17:9, s. 1117-1124
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objectives To estimate productivity loss and associated indirect costs in high-risk patients treated for hyperlipidemia who experience cardiovascular (CV) events. Methods Retrospective population-based cohort study conducted using Swedish medical records linked to national registers. Patients were included based on prescriptions of lipid-lowering therapy between 1 January 2006 and 31 December 2011 and followed until 31 December 2012 for identification of CV events and estimation of work productivity loss (sick leave and disability pension) and indirect costs. Patients were stratified into two cohorts based on CV risk level: history of major cardiovascular disease (CVD) and coronary heart disease (CHD) risk equivalent. Propensity score matching was applied to compare patients with new events (cases) to patients without new events (controls). The incremental effect of CV events was estimated using a difference-in-differences design, comparing productivity loss among cases and controls during the year before and the year after the cases event. Results The incremental effect on indirect costs was largest in the CHD risk equivalent cohort (n = 2946) at (sic)3119 (P value amp;lt;0.01). The corresponding figure in the major CVD history cohort (n = 4508) was (sic)2210 (P value amp;lt;0.01). There was substantial variation in productivity loss depending on the type of event. Transient ischemic attack and revascularization had no significant effect on indirect costs. Myocardial infarction ((sic)), unstable angina ((sic)) and, most notably, ischemic stroke ((sic)) yielded substantial incremental cost estimates (P values amp;lt;0.01). Conclusions Indirect costs related to work productivity losses of CV events are substantial in Swedish high-risk patients treated for hyperlipidemia and vary considerably by type of event.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)
SAMHÄLLSVETENSKAP  -- Ekonomi och näringsliv (hsv//swe)
SOCIAL SCIENCES  -- Economics and Business (hsv//eng)

Keyword

Cardiovascular disease; Hyperlipidemia; Indirect costs; Productivity

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view